In the original publication [1], support from Clinical Trials Center of Incheon St. Mary’s Hospital, The Catholic University of Korea, was not included. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Sung S.-Y., Lee S.-W., Hong J.H., Kang H.J., Lee S.J., Kim M., Kim J.-H., Kwak Y.-K. Linear Tumor Regression of Rectal Cancer in Daily MRI during Preoperative Chemoradiotherapy: An Insight of Tumor Regression Velocity for Personalized Cancer Therapy. Cancers. 2022;14:3749. doi: 10.3390/cancers14153749. [DOI] [PMC free article] [PubMed] [Google Scholar]